The impact of cigarette/tobacco smoking on oral candidosis: An overview

Oral Diseases

Volumn 11, Issue 5, 2005, Pages 268-273

  Soysa, N S ^a   Ellepola, A N B ^a  

^a UNIVERSITY OF PERADENIYA   (Sri Lanka)

Author keywords

Candida; Oral candidosis; Tobacco

Indexed keywords

ADRENALIN; AROMATIC HYDROCARBON; CIGARETTE SMOKE; ENZYME INHIBITOR; GAMMA INTERFERON; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; IMMUNOGLOBULIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; N BENZYL N METHYLNITROSAMINE; NICOTINE;

ADRENALIN BLOOD LEVEL; BACTERIAL FLORA; CANDIDA; CELLULAR IMMUNITY; CIGARETTE SMOKING; DENTURE; GLOSSITIS; GLUCOSE BLOOD LEVEL; HEAD AND NECK CANCER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; KERATINOCYTE; KERATOSIS; LEUKOPLAKIA; MOUTH MUCOSA; NEUTROPHIL; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STOMATITIS; T LYMPHOCYTE; TH1 CELL; THRUSH; CANDIDA ALBICANS; DISEASE PREDISPOSITION; HETEROZYGOTE; MICROBIOLOGY; PATHOGENICITY; SMOKING;

CANDIDA ALBICANS; CANDIDIASIS, ORAL; CARRIER STATE; DENTURE, COMPLETE; DISEASE SUSCEPTIBILITY; HIV INFECTIONS; HUMANS; SMOKING; STOMATITIS, DENTURE;

EID: 25144516078     PISSN: 1354523X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2005.01115.x     Document Type: Review

References (50)

1. Abu-Elteen KH, Abu-Elteen RM (1998). The prevalence of Candida albicans populations in the mouths of complete denture wearers. New Microbiol 21: 41-48.
2. Alkumru HN, Beydemir K (1992). The prevalence of Candida albicans in complete denture and removable partial denture wearers: a comparative study. J Marmara Univ Dent Fac 1: 218-222.
3. Almeida OP, Scully C (2002). Fungal infections of the mouth. Braz J Oral Sci 1: 19-26.
4. Arendorf TM, Walker DM (1980). The prevalence and intraoral distribution of Candida albicans in man. Arch Oral Biol 25: 1-10.
5. Arendorf TM, Walker DM (1984). Tobacco smoking and denture wearing as local aetiological factors in median rhomboid glossitis. Int J Oral Surg 13: 411-415.
6. Arendorf TM, Walker DM, Kingdom RJ et al (1983). Tobacco smoking and denture wearing in oral candidal leukoplakia. Br Dent J 155: 340-343.
7. Arredondo J, Nguyen VT, Chernyavsky AI et al (2001). A receptor-mediated mechanism of nicotine toxicity in oral keratinocytes. Lab Invest 81: 1653-1668.
8. Barbeau J, Seguin J, Goulet JP et al (2003). Reassessing the presence of Candida albicans in denture-related stomatitis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 95: 51-59.
9. Bastiaan RJ, Reade RC (1982). The prevalence of Candida albicans in the mouths of tobacco smokers with and without oral mucous membrane keratoses. Oral Surg Oral Med Oral Pathol 53: 148-151.
10. Brownlee M, Cerami A, Vlassara H (1988). Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318: 1315-1321.
11. Burger MP, Hollema H, Gouw AS et al (1993). Cigarette smoking and human papillomavirus in patients with reported cervical cytological abnormality. BMJ 306: 749-752.
12. Campisi G, Pizzo G, Milici ME et al (2002). Candidal carriage in the oral cavity of human immunodeficiency virus-infected subjects. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 93: 281-286.
13. Chattopadhyay A, Gray LR, Patton LL et al (2004). Salivary secretory leukocyte protease inhibitor and oral candidiasis in human immunodeficiency virus type 1-infected persons. Infect Immun 72: 1956-1963.
14. Colman G, Beighton D, Chalk A et al (1976). Cigarette smoking and the microbial flora of the mouth. Aust Dent J 21: 111-118.
15. Conley LJ, Bush TJ, Buchbinder SP et al (1996). The association between cigarette smoking and selected HIV-related medical conditions. AIDS 10: 1121-1126.
16. Crockett DN, O'Grady JF, Reade PC (1992). Candida species and Candida albicans morphotypes in erythematous candidiasis. Oral Surg Oral Med Oral Pathol 73: 559-563.
17. Daftary DK, Mehta FS, Gupta PC et al (1972). The presence of Candida in 723 oral leucoplakias among Indian villagers. Scand J Dent Res 80: 75-79.
18. Daniels TE, Chou L, Greenspan JS et al (1992). Reduction of Langerhans cells in smokeless tobacco-associated oral mucosal lesions. J Oral Pathol Med 21: 100-104.
19. Epstein JB, Freilich MM, Le ND (1993). Risk factors for oropharyngeal candidiasis in patients who receive radiation therapy for malignant conditions of the head and neck. Oral Surg Oral Med Oral Pathol 76: 169-174.
20. Fidel PL Jr (2002). Immunity to Candida. Oral Dis 8: 69-75.
21. Fongsmut T, Deerochanawong C, Prachyabrued W (1998). Intraoral Candida in Thai diabetes patients. J Med Assoc Thai 81: 449-453.
22. Galai N, Park LP, Wesch J et al (1997). Effect of smoking on the clinical progression of HIV-1 infection. J Acquir Immune Defic Syndr Hum Retrovirol 14: 451-458.
23. Gergely L, Uri J (1966). Day-by-day variation in the mycotic flora of the mouth. Arch Oral Biol 11: 15-19.
24. Greenspan D, Komaroff E, Redford M et al (2000). Oral mucosal lesions and HIV viral load in the Women's Interagency HIV Study (WIHS). J Acquir Immune Defic Syndr 25: 44-50.
25. Guggenheimer J, Moore PA, Rossie K et al (2000). Insulin-dependent diabetes mellitus and oral soft tissue pathologies: II. Prevalence and characteristics of Candida and candidal lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 89: 570-576.
26. Holmstrup P, Bessermann M (1983). Clinical, therapeutic and pathogenic aspects of chronic oral multifocal candidosis. Oral Surg Oral Med Oral Pathol 56: 388-395.
27. Hsia CC, Sun TT, Wang YY et al (1981). Enhancement of formation of esophageal carcinogen benzylmethylnitrosoamine from its precursors by Candida albicans. Proc Natl Acad Sci U S A 78: 1878-1881.
28. Johnson NW, Bain CA (2000). Tobacco and oral disease. EU-Working Group on Tobacco and Oral Health. Br Dent J 189: 200-206.
29. Kadir T, Pisiriciler S, Akyuz S et al (2002). Mycological and cytological examination of oral candidal carriage in diabetic patients and non-diabetic control subjects: thorough analysis of local aetiologic and systemic factors. J Oral Rehabil 29: 452-457.
30. Krogh P, Hald B, Holmstrup P (1987). Possible mycological etiology of oral mucosal cancer: catalytic potential of infecting Candida albicans and other yeasts in production of N-nitrosobenzylmethylamine. Carcinogenesis 8: 1543-1548.
31. Lundman BM, Asplund K, Norberg A (1990). Smoking and metabolic control in patients with insulin-dependent diabetes mellitus. J Intern Med 227: 101-106.
32. Macgregor ID (1989). Effects of smoking on oral ecology. A review of the literature. Clin Prev Dent 11: 3-7.
33. Manfredi M, McCullough MJ, Al-Karaawi ZM et al (2002). The isolation, identification and molecular analysis of Candida spp. isolated from the oral cavities of patients with diabetes mellitus. Oral Microbiol Immunol 17: 181-185.
34. Masipa JN, Hauman CH, Raubenheimer EJ (1992). Oral carriage of Candida species in patients visiting the Medunsa Dental Clinic. J Dent Assoc S Afr 47: 407-409.
35. Oliver DE, Shillitoe EJ (1984). Effects of smoking on the prevalence and intraoral distribution of Candida albicans. J Oral Pathol 13: 265-270.
36. Palacio H, Hilton JF, Canchola AJ et al (1997). Effect of cigarette smoking on HIV-related oral lesions. J Acquir Immune Defic Syndr Hum Retrovirol 14: 338-342.
37. Ramirez-Amador V, Silverman S Jr Mayer P et al (1997). Candidal colonization and oral candidiasis in patients undergoing oral and pharyngeal radiation therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 84: 149-153.
38. Reichart, PA, Samaranayake LP, Philipsen HP (2000). Pathology and clinical correlates in oral candidiasis and its variants: a review. Oral Dis 6: 85-91.
39. Ritz E, Benck U, Franek E et al (1998). Effects of smoking on renal hemodynamics in healthy volunteers and in patients with glomerular disease. J Am Soc Nephrol 9: 1798-1804.
40. Romani L, Puccetti P, Bistoni F (1996). Biological role of Th cell subsets in candidiasis. Chem Immunol 63: 115-137.
41. Samaranayake LP (1990). Host factors and oral candidosis. In: Samaranayake LP, MacFarlane TW, eds. Oral candidosis London, UK: Butterworth and Company Ltd, pp. 66-103.
42. Schoofs AG, Odds FC, Colebunders R et al (1998). Cross-sectional study of oral Candida carriage in a human immunodeficiency virus (HIV)-seropositive population: predisposing factors, epidemiology and antifungal susceptibility. Mycoses 41: 203-211.
43. Schuman P, Ohmit SE, Sobel JD et al (1998). Oral lesions among women living with or at risk for HIV infection. Am J Med 104: 559-564.
44. Shin ES, Chung SC, Kim YK et al (2003). The relationship between oral Candida carriage and the secretor status of blood group antigens in saliva. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 96: 48-53.
45. Slavinsky J, Myers T, Swoboda RK et al (2002). Th1/Th2 cytokine profiles in saliva of HIV-positive smokers with oropharyngeal candidiasis. Oral Microbiol Immunol 17: 38-43.
46. Soysa NS, Samaranayake LP, Ellepola ANB (2004). Cytotoxic drugs, radiotherapy and oral candidiasis. Oral Oncol 40: 971-978.
47. Steele C, Leigh J, Swoboda R et al (2000). Growth inhibition of Candida by human oral epithelial cells. J Infect Dis 182: 1479-1485.
48. Steele C, Leigh J, Swoboda R et al (2001). Potential role for a carbohydrate moiety in anti-Candida activity of human oral epithelial cells. Infect Immun 69: 7091-7099.
49. Tapper-Jones LM, Aldred MJ, Walker DM et al (1981). Candidal infections and populations of Candida albicans in mouths of diabetics. J Clin Pathol 34: 706-711.
50. Willis AM, Coulter WA, Fulton CR et al (1999). Oral candidal carriage and infection in insulin-treated diabetic patients. Diabet Med 16: 675-679.